• William B. Herring


This chapter defines the concepts and skills pertaining to the broad specialty of hematology that should belong to the average family physician. Suggestions are offered for hematologic procedures in the office laboratory, for determining when consultation with a hematologist is indicated, and for the important role that the family physician should play in the care of patients with hematologic problems whose complexity requires a continuing role for the hematologist beyond that normally expected of a consultant. Family physicians will vary widely in their interest, experience, and competence in the field of hematology, so the author has chosen as his reference point that level of knowledge and skills that should be achieved in a residency program in family medicine.


Iron Deficiency Sickle Cell Disease Family Physician Iron Overload Aplastic Anemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abildgaard CF: Current concepts in the management of hemophilia. Semin Hematol 12:223, 1975PubMedGoogle Scholar
  2. 2.
    Adams EB: Anemia associated with protein deficiency. Semin Hematol 7:55, 1970PubMedGoogle Scholar
  3. 3.
    Ahn YS, Harrington WJ: Treatment of idiopathic thrombocytopenic purpura (ITP). Annu Rev Med 28: 299, 1977PubMedCrossRefGoogle Scholar
  4. 4.
    Albahary C: Lead and hemopoiesis. Am J Med 52:367, 1972PubMedCrossRefGoogle Scholar
  5. 5.
    Barrett-Conner E: Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine 50:97, 1971Google Scholar
  6. 6.
    Benz EJ, Forget BG: The molecular genetics of the thalassemia syndromes. Prog Hematol 9: 107, 1975PubMedGoogle Scholar
  7. 7.
    Beutler E: A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood 28:553, 1966PubMedGoogle Scholar
  8. 8.
    Blood Component Therapy. Myhre BA (ed). Washington, American Association of Blood Banks, 1975Google Scholar
  9. 9.
    Blood transfusion and blood products. Cash JD (ed) : Clin Haematol 5: 1, 1976Google Scholar
  10. 10.
    Bowman WD Jr: Abnormal (“ringed”) sideroblasts in various hematologic and non-hematologic disorders. Blood 18:662, 1961PubMedGoogle Scholar
  11. 11.
    Brain MC: Hazards of splenectomy. In Nathan DG, Oski FA (eds) : Hematology of Infancy and Childhood. Philadelphia, Saunders, 1974, p. 248Google Scholar
  12. 12.
    Buckner CD, Cliff RA, Fefer A, Neiman P, Storb R, Thomas ED: Human marrow transplantation. Current status. Prog Hematol 8:299, 1975Google Scholar
  13. 13.
    Cartwright GE, Deiss A: Sideroblasts, siderocytes, and sideroblastic anemia. N Engl J Med 292:185, 1975PubMedCrossRefGoogle Scholar
  14. 14.
    Cartwright GE, Lee GR: The anemia of chronic disorders. Br J Haematol 21:147, 1971PubMedCrossRefGoogle Scholar
  15. 15.
    Crosby WH: Pica. JAMA 235:2765, 1976Google Scholar
  16. 16.
    Diamond LK: Hematological consequences of longterm corticosteroid treatment. In Meyler L, Peck HM (eds) : Drug-Induced Diseases. New York, Excerpta Medica, 1968, pp 177–181Google Scholar
  17. 17.
    Gavrilis P, Rothenberg SP, Guy R: Correlation of low serum IgM levels with absence of functional splenic tissue in sickle cell disease syndromes. Am J Med 57: 542, 1974PubMedCrossRefGoogle Scholar
  18. 18.
    Genton E, Gent M, Hirsh J, Harker LA: Plateletinhibiting drugs in the prevention of clinical thrombotic disease. N Engl J Med 293:1174, 1975PubMedCrossRefGoogle Scholar
  19. 19.
    Gilliland BC: Coombs-negative immune hemolytic anemia. Semin Hematol 13:267, 1976PubMedGoogle Scholar
  20. 20.
    Hagler L, Pastore RA, Bergin JJ: Aplastic anemia following viral hepatitis. Medicine 54:139, 1975PubMedGoogle Scholar
  21. 21.
    Harker LA: Hemostatis Manual, 2nd ed. Philadelphia, Davis, 1974Google Scholar
  22. 22.
    Harkness DR, Roth S: Clinical evaluation of cyanate in sickle cell anemia. Prog Hematol 9: 157, 1975PubMedGoogle Scholar
  23. 23.
    Harris JW, Kellermeyer RW: The Red Cell, rev. ed. Cambridge, Mass, Harvard Univ Press, 1970Google Scholar
  24. 24.
    Herbert V: Megaloblastic anemias. In Beeson PB, McDermott W (eds) : Textbook of Medicine, 14th ed. Philadelphia, Saunders, 1975, p 1404Google Scholar
  25. 25.
    Herzig GP, Graw RG: Granulocyte transfusion for bacterial infections. Prog Hematol 9:207, 1975PubMedGoogle Scholar
  26. 26.
    Hillman RS, Finch CA: Red Cell Manual, 4th ed. Philadelphia, Davis, 1974Google Scholar
  27. 27.
    Hines JD: Effect of pyridoxine plus chronic phlebotomy on the function and morphology of bone marrow and liver in pyridoxine-responsive sideroblastic anemia. Semin Hematol 13:133, 1976PubMedGoogle Scholar
  28. 28.
    Hines JD, Grasso JA: The sideroblastic anemias. Semin Hematol 7 : 86, 1970PubMedGoogle Scholar
  29. 29.
    Jacobs A: Iron overload. Clinical and pathologic aspects. Semin Hematol 14:89, 1977PubMedGoogle Scholar
  30. 30.
    Jones SR, Binder RA, Donowho EM Jr: Sudden death in sickle cell trait. N Engl J Med 282:323, 1970PubMedCrossRefGoogle Scholar
  31. 31.
    Klug PP, Lessin LL, Radice P: Rheological aspects of sickle cell disease. Arch Intern Med 133:577, 1974PubMedCrossRefGoogle Scholar
  32. 32.
    Krantz SB: Pure red cell aplasia. Br J Haematol 25:1, 1973PubMedCrossRefGoogle Scholar
  33. 33.
    Lange RL: Erythrocytosis associated with normal bloodgas values. Adv Intern Med 21:309, 1976PubMedGoogle Scholar
  34. 34.
    Lewis SM, Verwilghen RL: Dyserythropoiesis and dyserythropoietic anemias. Prog Hematol 8:99, 1973PubMedGoogle Scholar
  35. 35.
    Miescher PA: Drug-induced thrombocytopenia. Semin Hematol 10:311, 1973PubMedGoogle Scholar
  36. 36.
    Moore RA, Brunner CM, Sandusky WR, Leavell BS: Felty’s syndrome. Long-term follow-up after splenectomy. Ann Intern Med 75:381, 1971PubMedCrossRefGoogle Scholar
  37. 37.
    Nagel RL, Bookchin RM: Human hemoglobin mutants with abnormal oxygen binding. Semin Hematol 11:385, 1974PubMedGoogle Scholar
  38. 38.
    Pearson HA, O’Brien RT: The management of thalassemia major. Semin Hematol 12:255, 1975PubMedGoogle Scholar
  39. 39.
    Personal observationsGoogle Scholar
  40. 40.
    Pisciotta AV: Immune and toxic mechanisms in druginduced agranulocytosis. Semin Hematol 10:279, 1973PubMedGoogle Scholar
  41. 41.
    Powars DR: Natural history of sickle cell disease. Semin Hematol 12:267, 1975PubMedGoogle Scholar
  42. 42.
    Quie PG: Pathology of bactericidal power of neutrophils. Semin Hematol 12 : 143, 1975PubMedGoogle Scholar
  43. 43.
    Reticuloendothelial disorders. The lipidoses. Sawitsky A (ed). Semin Hematol 9:225, 1972Google Scholar
  44. 44.
    Rizza CR: Coagulation factor therapy. Clin Haematol 5:113, 1976Google Scholar
  45. 45.
    Robinson WA, Mangalik A: The kinetics and regulation of granulopoieses. Semin Hematol 12:7, 1975PubMedGoogle Scholar
  46. 46.
    Roselle HA: Association of laundry starch and drug ingestion with anemia in New York City. Arch Intern Med 125:57, 1970PubMedCrossRefGoogle Scholar
  47. 47.
    Sagone AL Jr, Balcerzak SP: Smoking as a cause of erythrocytosis. Ann Intern Med 82:512, 1975PubMedCrossRefGoogle Scholar
  48. 48.
    Schilling RF: Hereditary spherocytosis. A study of splenectomized persons. Semin Hematol 13:169, 1976PubMedGoogle Scholar
  49. 49.
    Storb R, Prentice RL, Thomas EO: Marrow transplantation for treatment of aplastic anemia. N Engl J Med 296:61, 1977PubMedCrossRefGoogle Scholar
  50. 50.
    Straus DJ: Hematologic aspects of alcoholism. Semin Hematol 10:183, 1973PubMedGoogle Scholar
  51. 51.
    Stuart MJ: Inherited defects of platelet function. Semin Hematol 12:233, 1975PubMedGoogle Scholar
  52. 52.
    Utsinger PD: Lymphocyte changes in viral infections. Ann Intern Med 83:82, 1975PubMedCrossRefGoogle Scholar
  53. 53.
    Ward HP, Block MG: The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 50:357, 1971PubMedCrossRefGoogle Scholar
  54. 54.
    Weed RI: Diseases of the spleen. In Beeson PB, McDermott W (eds) : Textbook of Medicine, 14th ed. Philadelphia, Saunders, 1975, pp 1550–1554Google Scholar
  55. 55.
    Weiss L, Tavassoli M: Anatomical hazards to the passage of erythrocytes through the spleen. Semin Hematol 7:372, 1970PubMedGoogle Scholar
  56. 56.
    Williams DM, Lynch RE, Cartwright GE: Drug-induced aplastic anemia. Semin Hematol 10:195, 1975Google Scholar
  57. 57.
    Williams WJ, Beutler E, Erslev AJ, Rundles RW: Hematology. New York, McGraw-Hill, 1972Google Scholar
  58. 58.
    Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Athens JW, Foerster J: Clinical Hematology, 7th ed. Philadelphia, Lea & Febiger, 1974Google Scholar
  59. 59.
    Young LE: Hemolytic disorders. Intracorpuscular abnormalities. In Beeson PB, McDermott W (eds) : Textbook of Medicine, 14th ed. Philadelphia, Saunders, 1975, p 1438Google Scholar
  60. 60.
    Zeulzer WW, Kaplan J: The child with lymphadenopathy. Semin Hematol 12:323, 1975Google Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • William B. Herring

There are no affiliations available

Personalised recommendations